Hypotension, Orthostatic
14
0
0
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
14.3%
2 terminated out of 14 trials
81.8%
-4.7% vs benchmark
29%
4 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
Controlling Orthostatic Hypotension in People with Cervical Spinal Cord Injury
Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease
Effects of Insulin on Hypotension and Sarcopenia
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
A Study for Patients With Neurogenic Orthostatic Hypotension
Evaluation of Changes of Venous Return After Spinal and Epidural Analgesia and Anesthesia by Ultrasound Guided Vena Cava Diameter Measurement
Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
Posture Detection for Automated Abdominal Binder
Study of Pulse Pressure During Tilttable and Erigo® in Adult Patients With Acquired Brain Injury
Orthostatic Hypotension in Rehabilitation Patients
Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery